Task: Answer the multiple choice question.
Query: Which drug exhibits a -2.196% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCC(C(=O)NCCCN(CC)Cc1ccccc1)n1nc(C)c2sc3ccccc3c2c1=O
b.) O=C(NCCCc1ccccc1)N1CCOCC1
c.) Cc1cccnc1NC(=O)Cn1nc(-c2ccccc2)oc1=S
d.) CN(CC(=O)Nc1cccc(S(=O)(=O)NC2=NCCC2)c1)Cc1ccccc1Cl
Answer: c. Cc1cccnc1NC(=O)Cn1nc(-c2ccccc2)oc1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccnc1NC(=O)Cn1nc(-c2ccccc2)oc1=S
Cc1cccnc1NC(=O)Cn1nc(-c2ccccc2)oc1=S
N-(3-methylpyridin-2-yl)-2-(5-phenyl-2-sulfanylidene-1,3,4-oxadiazol-3-yl)acetamide